PHS
PFM Health Sciences’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,512,348
| Closed | -$20.1M | – | 81 |
|
|
2022
Q1 | $20.1M | Hold |
3,512,348
| – | – | 0.75% | 45 |
|
|
2021
Q4 | $32.1M | Buy |
3,512,348
+518,802
| +17% | +$4.74M | 1.09% | 42 |
|
|
2021
Q3 | $32M | Buy |
2,993,546
+794,489
| +36% | +$8.49M | 0.94% | 38 |
|
|
2021
Q2 | $34.1M | Buy |
2,199,057
+100,479
| +5% | +$1.56M | 1.07% | 36 |
|
|
2021
Q1 | $34M | Buy |
2,098,578
+87,101
| +4% | +$1.41M | 1.04% | 32 |
|
|
2020
Q4 | $42.6M | Buy |
2,011,477
+139,465
| +7% | +$2.95M | 1.5% | 23 |
|
|
2020
Q3 | $27.7M | Sell |
1,872,012
-359,390
| -16% | -$5.33M | 1.28% | 26 |
|
|
2020
Q2 | $32.8M | Sell |
2,231,402
-250,515
| -10% | -$3.69M | 1.7% | 19 |
|
|
2020
Q1 | $29.1M | Buy |
+2,481,917
| New | +$29.1M | 2.39% | 18 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 119 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 110 |
|
|
2017
Q3 | – | Sell |
-3,344,517
| Closed | -$46.3M | – | 88 |
|
|
2017
Q2 | $46.3M | Sell |
3,344,517
-588,213
| -15% | -$8.15M | 1.25% | 28 |
|
|
2017
Q1 | $59M | Buy |
3,932,730
+1,199,453
| +44% | +$18M | 1.48% | 23 |
|
|
2016
Q4 | $35.8M | Sell |
2,733,277
-656,975
| -19% | -$8.61M | 1.01% | 30 |
|
|
2016
Q3 | $58.4M | Buy |
3,390,252
+39,148
| +1% | +$675K | 1.71% | 21 |
|
|
2016
Q2 | $60.5M | Buy |
3,351,104
+277,634
| +9% | +$5.01M | 1.82% | 17 |
|
|
2016
Q1 | $58.4M | Buy |
3,073,470
+296,006
| +11% | +$5.62M | 1.8% | 20 |
|
|
2015
Q4 | $74.2M | Sell |
2,777,464
-185,192
| -6% | -$4.94M | 2.25% | 14 |
|
|
2015
Q3 | $72.3M | Buy |
2,962,656
+1,151,490
| +64% | +$28.1M | 2.03% | 16 |
|
|
2015
Q2 | $56.4M | Buy |
+1,811,166
| New | +$56.4M | 1.43% | 26 |
|